Not applicableEnded earlyNCT02545114What this trial is testingTolvaptan for Patients With Acute Neurological InjuriesWho this might be right forHyponatremiaSIADH Polderman, Kees, H., MD, PhD 25
Not applicableLooking for participantsNCT07528365What this trial is testingUrea for Treatment of Hyponatremia in Patients With SIAD Unresponsive to Fluid RestrictionWho this might be right forSIAD - Syndrome of Inappropriate Antidiuresis University of Turin, Italy 20
Not applicableStudy completedNCT03924674What this trial is testingSOFI: A Quality Improvement Project to Standardize Use of Intravenous Fluids in Hospitalized Pediatric PatientsWho this might be right forIntravenous FluidsFluid and Electrolyte ImbalanceADH Inappropriate Seattle Children's Hospital 106
Not applicableStudy completedNCT01056848What this trial is testingInternational, Multicenter Study of a Twenty-eight Week, Open-label, Titrated Oral Lixivaptan Administration in Patients With Chronic Hyponatremia: Extension to Studies CK-LX3401, 3405, and 3430Who this might be right forHyponatremia With Normal Extracellular Fluid VolumeHyponatremia With Excess Extracellular Fluid Volume CardioKine Inc. 135
Large-scale testing (Phase 3)Ended earlyNCT01227512What this trial is testingEffects of Tolvaptan vs Fluid Restriction in Hospitalized Subjects With Dilutional HyponatremiaWho this might be right forHyponatremiaDilutional HyponatremiaInappropriate ADH Syndrome Otsuka Pharmaceutical Development & Commercialization, Inc. 124
Post-approval studies (Phase 4)WithdrawnNCT00298753What this trial is testingUrinary Aquaporine 2 in Patients With Syndrome of Inappropriate ADH-secretion Caused by Treatment With Antiepileptic MedicineWho this might be right forSyndrome of Inappropriate ADH-secretion Regional Hospital Holstebro
Not applicableStudy completedNCT01313975What this trial is testingElectrolyte and Fluid Disturbances in Subarachnoid Hemorrhage and Traumatic Brain InjuryWho this might be right forElectrolyte DisturbancesSubarachnoid HemorrhageTraumatic Brain Injury+1 more Insel Gruppe AG, University Hospital Bern 85
Not applicableActive Not RecruitingNCT04790175What this trial is testingSamsca Post-marketing General Drug Use-results Survey in Patients With Hyponatremia in SIADHWho this might be right forAntidiuretic Hormone, Inappropriate Secretion Otsuka Pharmaceutical Co., Ltd. 300
Large-scale testing (Phase 3)Study completedNCT00264927What this trial is testingEfficacy and Safety of SR121463B in Patients With Syndrome of Inappropriate Antidiuretic Hormone SecretionWho this might be right forInappropriate ADH SyndromeHyponatremia Sanofi 77
Not applicableUnknownNCT01509170What this trial is testingThe Clinical and Laboratory Characteristics of Recurrent Drug- Related HyponatremiaWho this might be right forHyponatremiaSIADH Hadassah Medical Organization 500
Not applicableStudy completedNCT04987385What this trial is testingEffect of Protein Supplementation on Plasma Sodium Levels and Urinary Urea Excretion in Patients With SIADWho this might be right forSyndrome of Inappropriate Antidiuresis (SIAD) University Hospital, Basel, Switzerland 18
Not applicableUnknownNCT01228682What this trial is testingPost-Authorisation Safety Study of Samsca (Tolvaptan) Used in Routine Medical PracticeWho this might be right forSIADHNon-SIADH HyponatremiaNon-Hyponatremia Otsuka Frankfurt Research Institute GmbH 200
Not applicableStudy completedNCT02548845What this trial is testingAn Observational Study to Describe the Adherence to the SEOM Algorithm for the Treatment of Hyponatraemia in SpainWho this might be right forHyponatremiaSyndrome of Inappropriate ADH (SIADH) Secretion Otsuka Pharmaceutical Europe Ltd 70
Not applicableStudy completedNCT04256499What this trial is testingWater Load Test Value for HyponatremiaWho this might be right forSIAD - Syndrome of Inappropriate AntidiuresisHyponatremia European Georges Pompidou Hospital 150
Large-scale testing (Phase 3)Study completedNCT00876798What this trial is testingA Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety and Tolerability of Oral Lixivaptan Capsules in Subjects With Euvolemic HyponatremiaWho this might be right forEuvolemic Hyponatremia CardioKine Inc. 206
Large-scale testing (Phase 3)Study completedNCT02729766What this trial is testingEffects of Empagliflozin an SGLT2-Inhibitor on Healthy Volunteers With Induced Hypotonic Hyponatremia - the DIVE StudyWho this might be right forInappropriate ADH Syndrome University Hospital, Basel, Switzerland 15
Post-approval studies (Phase 4)Study completedNCT04447911What this trial is testingEffects of the SGLT2 Inhibitor Empagliflozin in Patients With Euvolemic and Hypervolemic HyponatremiaWho this might be right forHyponatremiaSIADHLiver Failure+1 more University Hospital, Basel, Switzerland 113
Large-scale testing (Phase 3)Ended earlyNCT00728091What this trial is testingA Phase III Study Evaluating the Efficacy and Safety of Satavaptan Versus Placebo in Patients With Dilutional HyponatremiaWho this might be right forHyponatremiaInappropriate ADH Syndrome Sanofi 2
Testing effectiveness (Phase 2)Study completedNCT02009878What this trial is testingA PK Study of 3 Dosages of Tolvaptan in Patients With Syndrome of Inappropriate Antidiuretic Hormone Secretion (SIADH)Who this might be right forSyndrome of Inappropriate Antidiuretic Hormone Secretion (SIADH) Otsuka Pharmaceutical Development & Commercialization, Inc. 30
Large-scale testing (Phase 3)Study completedNCT03202667What this trial is testingEffects of the SGLT2-inhibitor Empagliflozin on Patients With Chronic SIADH - the SANDx StudyWho this might be right forSIAD - Syndrome of Inappropriate AntidiuresisHyponatremia University Hospital, Basel, Switzerland 17